DJIA 17,810.06 91.06 0.51%
NASDAQ 4,712.97 11.10 0.24%
S&P 500 2,063.50 10.75 0.52%
market minute promo

0.95 -0.06 (-5.47%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

LXRX $0.95 -5.47%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.95
Previous Close $1.01
Daily Range $0.90 - $0.96
52-Week Range $0.90 - $2.45
Market Cap $489.1M
P/E Ratio -4.57
Dividend (Yield) $0.00 (0.0%)
Volume 20,497,536
Average Daily Volume 1,303,455
Current FY EPS -$0.21

Sector

Healthcare

Industry

Drugs

Lexicon Pharmaceuticals, Inc. (LXRX) Description

A biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease. Website: http://www.lexicon-genetics.com/

News & Commentary

7 States Where Diabetes Prevalence Is the Highest

More than 29 million people now have diabetes, but its occurrence is the highest within these seven U.S. states.

Lexicon Pharmaceuticals Fights On

Stocks Hitting 52-Week Lows

How To Be Smarter About Risk Management

US Stock Futures Rise Ahead Of Earnings

Mid-Afternoon Market Update: Best Buy Rises After Upbeat Results; GoPro Shares Slide

Health Care Sector Update for 11/20/2014: LXRX,CYBX,RMTI

Mid-Day Losers From November 20: Lexicon Pharmaceuticals, GoPro, Donaldson Company, Keurig Green Mou

Mid-Day Losers From November 20: Lexicon Pharmaceuticals, GoPro, Donaldson Company, Keurig Green Mountain

Mid-Day Market Update: U.S. Stocks Turn Higher; Williams-Sonoma Shares Climb On Earnings Beat

Lexicon Announces Proposed Common Stock Offering Of $50M In Shares

Lexicon Pharmaceuticals' (LXRX) CEO Lonnel Coats on Q3 2014 Results - Earnings Call Transcript

See More LXRX News...

LXRX's Top Competitors

LXRX $0.95 (-5.47%)
Current stock: LXRX
AMGN $162.81 (0.08%)
Current stock: AMGN
GILD $100.58 (-0.01%)
Current stock: GILD
BIIB $303.55 (1.49%)
Current stock: BIIB